← Back to patent-cliff list
CAS 441741-65-7
methyl (E)-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylate
Codes: PANO-005
Application context (from source-drug indications)
Multiple myelomaPanobinostat LactateGliomaPanobinostat LactateDiffuse intrinsic pontine gliomaPanobinostat LactateDiffuse midline gliomaPanobinostat LactateMyelodysplastic syndromePanobinostat LactateAcute myeloid leukaemiaPanobinostat Lactate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Panobinostat Lactate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-methyl-1H-indole→2-(2-methyl-1H-indol-3-yl)-2-oxoacetamide→2-(2-methyl-1H-indol-3-yl)ethan-1-amine→methyl (E)-3-(4-formylphenyl)acrylate→methyl (E)-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.